CIAN Agro Industries & Infrastructure has announced a strategic move to bolster its infrastructure business through the acquisition of Vyankatesh Engineers Contractors Private Limited. The company has agreed to purchase a 100% stake in Vyankatesh Engineers, making it a wholly-owned subsidiary.

Acquisition Details

About Vyankatesh Engineers

Vyankatesh Engineers Contractors Private Limited, incorporated in 2010, specializes in construction and infrastructure development. The company's services encompass civil, architectural, electrical, and mechanical engineering.

Strategic Implications

The acquisition aligns with CIAN Agro Industries' strategy to expand its infrastructure business. By integrating Vyankatesh Engineers' capabilities, CIAN aims to strengthen its position in the construction and infrastructure development sector.

Transaction Details

CIAN Agro Industries has confirmed that the transaction is conducted at arm's length and does not fall under related party transactions. The company expects to complete the acquisition within 30 days, subject to customary closing conditions.

Regulatory Compliance

The board of directors of CIAN Agro Industries approved this acquisition during a meeting held on November 1, 2025. The company has duly informed the BSE Ltd. about this development, in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements.

This strategic acquisition marks a significant step for CIAN Agro Industries as it seeks to diversify and strengthen its infrastructure portfolio. The move may potentially open up new opportunities for the company in the construction and infrastructure development space.

CIAN Agro Industries & Infrastructure Ltd. (CIAN) has made significant strides in its global expansion efforts by securing and executing an export order for Ethiopia through a UAE aid program. This development marks a crucial milestone for the company's healthcare division and its foray into international markets.

Key Highlights of the Export Order

Details of the Initiative

CIAN has successfully completed its first shipment of medicines to Ethiopia, leveraging its partnership with Inthera Pharma Group. This consignment is part of a broader humanitarian and healthcare support initiative aimed at enhancing medical infrastructure and improving access to essential medicines in Ethiopia.

Significance of the Export Order

1. Global Outreach: This order represents CIAN's expanding presence in international markets, particularly in the African continent.
2. Diversification: The company demonstrates its versatility by venturing into the pharmaceutical export sector, showcasing its ability to adapt to diverse market needs.
3. Humanitarian Impact: By participating in an aid program, CIAN contributes to improving healthcare access in Ethiopia, aligning business growth with social responsibility.

Company's Disclosure

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, CIAN has officially disclosed this development to the Bombay Stock Exchange. This transparency ensures that shareholders and potential investors are kept informed about the company's strategic moves and expansion plans.

The successful execution of this export order could potentially open doors for CIAN to secure similar contracts in the future, both within Ethiopia and in other developing markets. It also positions the company as a reliable partner for international aid programs, which may lead to long-term growth opportunities in the pharmaceutical export sector.

As CIAN continues to expand its global footprint, stakeholders will be keen to observe how this new venture impacts the company's financial performance and market position in the coming quarters.